Evidence map›Paper›PMID 24876622›Full record

ReviewJournal of diabetes science and technology2014

Intraportal islet oxygenation.

Thomas M Suszynski, Efstathios S Avgoustiniatos, Klearchos K Papas

Abstract readReview
In one paragraph

Review in Journal of diabetes science and technology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Engineering Vascularized Islet Macroencapsulation Devices: AnFrontiers in bioengineering and biotechnology · 2022
    Article
  8. The Importance of Proper Oxygenation in 3D Culture.Frontiers in bioengineering and biotechnology · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Advances in islet encapsulation technologies.Nature reviews. Drug discovery · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas M SuszynskiDepartment of Surgery, University of Minnesota, Minneapolis, MN, USA.
Efstathios S AvgoustiniatosDepartment of Surgery, University of Minnesota, Minneapolis, MN, USA.
Klearchos K PapasDepartment of Surgery, University of Arizona, Tucson, AZ, USA kkpapas@surgery.arizona.edu.

Funding

Islet Protection from Hypoxia PosttransplantR41DK075211 · NIDDK · BIOINVENTIONS, LLC · PI PAPAS, KLEARCHOS K · 2010 to 2010
$332k
NIDDK NIH HHS R41 DK075211NIDDK NIH HHS R41DK075211
6 · The paper itself

Abstract

Islet transplantation (IT) is a promising therapy for the treatment of diabetes. The large number of islets required to achieve insulin independence limit its cost-effectiveness and the number of patients who can be treated. It is believed that >50% of islets are lost in the immediate post-IT period. Poor oxygenation in the early post-IT period is recognized as a possible reason for islet loss and dysfunction but has not been extensively studied. Several key variables affect oxygenation in this setting, including (1) local oxygen partial pressure (pO(2)), (2) islet oxygen consumption, (3) islet size (diameter, D), and (4) presence or absence of thrombosis on the islet surface. We discuss implications of oxygen-limiting conditions on intraportal islet viability and function. Of the 4 key variables, the islet size appears to be the most important determinant of the anoxic and nonfunctional islet volume fractions. Similarly, the effect of thrombus formation on the islet surface may be substantial. At the University of Minnesota, average size distribution data from clinical alloislet preparations (n = 10) indicate that >150-µm D islets account for only ~30% of the total islet number, but >85% of the total islet volume. This suggests that improved oxygen supply to the islets may have a profound impact on islet survivability and function since most of the β-cell volume is within large islets which are most susceptible to oxygen-limiting conditions. The assumption that the liver is a suitable islet transplant site from the standpoint of oxygenation should be reconsidered.

Indexed as

Islets of Langerhans TransplantationAnimalsCell DeathCell HypoxiaCell SizeDiabetes Mellitus, Type 1Graft SurvivalHumansIslets of LangerhansOxygenOxygen ConsumptionTreatment OutcomeOxygenanoxiahypoxiaintraportal transplantislet transplantoxygenation

Identifiers

PMID24876622
PMCPMC4455447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.